Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults

Kristen L. Nowak, Traci M. Bartz, Lorien Dalrymple, Ian H. de Boer, Bryan Kestenbaum, Michael G. Shlipak, Pranav S. Garimella, Joachim H. Ix, Michel Chonchol

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Within monocytes, 1,25-dihydroxyvitamin D [1,25(OH)2D] is important for production of cathelicidins, which in turn, are critical for antibacterial action. Fibroblast growth factor 23 (FGF23) decreases 1,25(OH)2D production and thus, could increase infection risk. We examined this possibility in 3141 community-dwelling adults ages ≥65 years old at baseline in the Cardiovascular Health Study using Cox proportional hazards models to examine the association between FGF23 concentrations and first infection-related hospitalizations and determine whether associations differed by the presence of CKD (eGFR<60 ml/min per 1.73 m2 [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]). Mean±SD age of participants was 78±5 years old, 60% of participants were women, and the median plasma FGF23 concentration was 70 (interquartile range, 53-99) relative units per milliliter. In fully adjusted models, higher FGF23 concentrations associated with higher risk of first infection-related hospitalization (hazard ratio [HR], 1.11; 95% confidence interval [95% CI], 1.03 to 1.20 per doubling of FGF23) during a median follow-up of 8.6 years. In participants with or without CKD (defined by eGFR), FGF23 concentration associated with first infection-related hospitalization with HRs of 1.24 (95% CI, 1.08 to 1.42) and 1.06 (95% CI, 0.97 to 1.17) per doubling of FGF23, respectively (P=0.13 for interaction). Associations did not differ between groups when stratified by urine albumin-to-creatinine ratio. In sensitivity analyses, the addition of serum calcium, phosphorus, 25-hydroxyvitamin D, intact parathyroid hormone, and 24,25-dihydroxyvitamin D did not meaningfully change the estimates. In conclusion, in community-dwelling older adults, higher plasma FGF23 concentrations independently associated with the risk of first infection-related hospitalization.

Original languageEnglish (US)
Pages (from-to)1239-1246
Number of pages8
JournalJournal of the American Society of Nephrology : JASN
Volume28
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Hospitalization
Infection
Independent Living
Confidence Intervals
Cathelicidins
Dihydroxycholecalciferols
fibroblast growth factor 23
Parathyroid Hormone
Proportional Hazards Models
Phosphorus
Monocytes
Albumins
Creatinine
Urine
Calcium
Health
Serum

Keywords

  • aging
  • chronic kidney disease
  • clinical epidemiology
  • infection
  • mineral metabolism

ASJC Scopus subject areas

  • Nephrology

Cite this

Nowak, K. L., Bartz, T. M., Dalrymple, L., de Boer, I. H., Kestenbaum, B., Shlipak, M. G., ... Chonchol, M. (2017). Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults. Journal of the American Society of Nephrology : JASN, 28(4), 1239-1246. https://doi.org/10.1681/ASN.2016040401

Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults. / Nowak, Kristen L.; Bartz, Traci M.; Dalrymple, Lorien; de Boer, Ian H.; Kestenbaum, Bryan; Shlipak, Michael G.; Garimella, Pranav S.; Ix, Joachim H.; Chonchol, Michel.

In: Journal of the American Society of Nephrology : JASN, Vol. 28, No. 4, 01.04.2017, p. 1239-1246.

Research output: Contribution to journalArticle

Nowak, KL, Bartz, TM, Dalrymple, L, de Boer, IH, Kestenbaum, B, Shlipak, MG, Garimella, PS, Ix, JH & Chonchol, M 2017, 'Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults', Journal of the American Society of Nephrology : JASN, vol. 28, no. 4, pp. 1239-1246. https://doi.org/10.1681/ASN.2016040401
Nowak, Kristen L. ; Bartz, Traci M. ; Dalrymple, Lorien ; de Boer, Ian H. ; Kestenbaum, Bryan ; Shlipak, Michael G. ; Garimella, Pranav S. ; Ix, Joachim H. ; Chonchol, Michel. / Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults. In: Journal of the American Society of Nephrology : JASN. 2017 ; Vol. 28, No. 4. pp. 1239-1246.
@article{cbe12969f8834c4fb38d872e58802725,
title = "Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults",
abstract = "Within monocytes, 1,25-dihydroxyvitamin D [1,25(OH)2D] is important for production of cathelicidins, which in turn, are critical for antibacterial action. Fibroblast growth factor 23 (FGF23) decreases 1,25(OH)2D production and thus, could increase infection risk. We examined this possibility in 3141 community-dwelling adults ages ≥65 years old at baseline in the Cardiovascular Health Study using Cox proportional hazards models to examine the association between FGF23 concentrations and first infection-related hospitalizations and determine whether associations differed by the presence of CKD (eGFR<60 ml/min per 1.73 m2 [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]). Mean±SD age of participants was 78±5 years old, 60{\%} of participants were women, and the median plasma FGF23 concentration was 70 (interquartile range, 53-99) relative units per milliliter. In fully adjusted models, higher FGF23 concentrations associated with higher risk of first infection-related hospitalization (hazard ratio [HR], 1.11; 95{\%} confidence interval [95{\%} CI], 1.03 to 1.20 per doubling of FGF23) during a median follow-up of 8.6 years. In participants with or without CKD (defined by eGFR), FGF23 concentration associated with first infection-related hospitalization with HRs of 1.24 (95{\%} CI, 1.08 to 1.42) and 1.06 (95{\%} CI, 0.97 to 1.17) per doubling of FGF23, respectively (P=0.13 for interaction). Associations did not differ between groups when stratified by urine albumin-to-creatinine ratio. In sensitivity analyses, the addition of serum calcium, phosphorus, 25-hydroxyvitamin D, intact parathyroid hormone, and 24,25-dihydroxyvitamin D did not meaningfully change the estimates. In conclusion, in community-dwelling older adults, higher plasma FGF23 concentrations independently associated with the risk of first infection-related hospitalization.",
keywords = "aging, chronic kidney disease, clinical epidemiology, infection, mineral metabolism",
author = "Nowak, {Kristen L.} and Bartz, {Traci M.} and Lorien Dalrymple and {de Boer}, {Ian H.} and Bryan Kestenbaum and Shlipak, {Michael G.} and Garimella, {Pranav S.} and Ix, {Joachim H.} and Michel Chonchol",
year = "2017",
month = "4",
day = "1",
doi = "10.1681/ASN.2016040401",
language = "English (US)",
volume = "28",
pages = "1239--1246",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "4",

}

TY - JOUR

T1 - Fibroblast Growth Factor 23 and the Risk of Infection-Related Hospitalization in Older Adults

AU - Nowak, Kristen L.

AU - Bartz, Traci M.

AU - Dalrymple, Lorien

AU - de Boer, Ian H.

AU - Kestenbaum, Bryan

AU - Shlipak, Michael G.

AU - Garimella, Pranav S.

AU - Ix, Joachim H.

AU - Chonchol, Michel

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Within monocytes, 1,25-dihydroxyvitamin D [1,25(OH)2D] is important for production of cathelicidins, which in turn, are critical for antibacterial action. Fibroblast growth factor 23 (FGF23) decreases 1,25(OH)2D production and thus, could increase infection risk. We examined this possibility in 3141 community-dwelling adults ages ≥65 years old at baseline in the Cardiovascular Health Study using Cox proportional hazards models to examine the association between FGF23 concentrations and first infection-related hospitalizations and determine whether associations differed by the presence of CKD (eGFR<60 ml/min per 1.73 m2 [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]). Mean±SD age of participants was 78±5 years old, 60% of participants were women, and the median plasma FGF23 concentration was 70 (interquartile range, 53-99) relative units per milliliter. In fully adjusted models, higher FGF23 concentrations associated with higher risk of first infection-related hospitalization (hazard ratio [HR], 1.11; 95% confidence interval [95% CI], 1.03 to 1.20 per doubling of FGF23) during a median follow-up of 8.6 years. In participants with or without CKD (defined by eGFR), FGF23 concentration associated with first infection-related hospitalization with HRs of 1.24 (95% CI, 1.08 to 1.42) and 1.06 (95% CI, 0.97 to 1.17) per doubling of FGF23, respectively (P=0.13 for interaction). Associations did not differ between groups when stratified by urine albumin-to-creatinine ratio. In sensitivity analyses, the addition of serum calcium, phosphorus, 25-hydroxyvitamin D, intact parathyroid hormone, and 24,25-dihydroxyvitamin D did not meaningfully change the estimates. In conclusion, in community-dwelling older adults, higher plasma FGF23 concentrations independently associated with the risk of first infection-related hospitalization.

AB - Within monocytes, 1,25-dihydroxyvitamin D [1,25(OH)2D] is important for production of cathelicidins, which in turn, are critical for antibacterial action. Fibroblast growth factor 23 (FGF23) decreases 1,25(OH)2D production and thus, could increase infection risk. We examined this possibility in 3141 community-dwelling adults ages ≥65 years old at baseline in the Cardiovascular Health Study using Cox proportional hazards models to examine the association between FGF23 concentrations and first infection-related hospitalizations and determine whether associations differed by the presence of CKD (eGFR<60 ml/min per 1.73 m2 [n=832] or urine albumin-to-creatinine ratio >30 mg/g [n=577]). Mean±SD age of participants was 78±5 years old, 60% of participants were women, and the median plasma FGF23 concentration was 70 (interquartile range, 53-99) relative units per milliliter. In fully adjusted models, higher FGF23 concentrations associated with higher risk of first infection-related hospitalization (hazard ratio [HR], 1.11; 95% confidence interval [95% CI], 1.03 to 1.20 per doubling of FGF23) during a median follow-up of 8.6 years. In participants with or without CKD (defined by eGFR), FGF23 concentration associated with first infection-related hospitalization with HRs of 1.24 (95% CI, 1.08 to 1.42) and 1.06 (95% CI, 0.97 to 1.17) per doubling of FGF23, respectively (P=0.13 for interaction). Associations did not differ between groups when stratified by urine albumin-to-creatinine ratio. In sensitivity analyses, the addition of serum calcium, phosphorus, 25-hydroxyvitamin D, intact parathyroid hormone, and 24,25-dihydroxyvitamin D did not meaningfully change the estimates. In conclusion, in community-dwelling older adults, higher plasma FGF23 concentrations independently associated with the risk of first infection-related hospitalization.

KW - aging

KW - chronic kidney disease

KW - clinical epidemiology

KW - infection

KW - mineral metabolism

UR - http://www.scopus.com/inward/record.url?scp=85019025987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019025987&partnerID=8YFLogxK

U2 - 10.1681/ASN.2016040401

DO - 10.1681/ASN.2016040401

M3 - Article

C2 - 28122946

AN - SCOPUS:85019025987

VL - 28

SP - 1239

EP - 1246

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 4

ER -